Identification of insulin-like growth factor-binding proteins in the circulation of four teleost fish species
✍ Scribed by Kelley, Kevin M. ;Siharath, Kimmakone ;Bern, Howard A.
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 589 KB
- Volume
- 263
- Category
- Article
- ISSN
- 0022-104X
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Insulin‐like growth factor‐binding proteins (IGF‐BPs) were demonstrated in the circulation of four teleost fish species. In the coho salmon (Oncorhynchus kisutch), serum binding of ^125^I‐labelled human IGF‐I (^125^I‐hIGF‐I) was competitively inhibited by addition of excess recombinant bovine IGF‐I (rbIGF‐I) in a manner similar to that when rat serum was used. Western‐ligand blot procedure using the same labelled hormone identified at least three major forms of IGF‐BPs in the plasma of all four teleost species investigated: coho salmon, striped bass (Morone saxatilis), tilapia (Oreochromis mossambicus), and longjawed mudsucker (Gillichthys mirabilis). The first form is around 40–50 kDa, may be regulated by growth hormone (GH), and seems to be a good candidate for the fish version of mammalian IGF‐BP3 (which is in the same size range and is GH‐regulated). The second and third forms are 29 kDa and 31 kDa and are good candidates for the fish versions of mammalian IGF‐BP1 and IGF‐BP2, respectively, as they appear to be regulated by insulin and are in the same size range as their mammalian counterparts. Functionally different classes of circulating IGF‐BPs may be conserved between fish and mammal. © 1992 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
The role and mechanisms of action of insulin-like growth factors (IGFs) in skin remain unclear. Epidermal keratinocytes possess IGF-I receptors and are responsive to IGF-I, which is primarily derived from underlying dermal fibroblasts. IGF binding proteins (IGFBPs), also synthesized by fibroblasts,
Previously we have shown that transforming growth factor b (TGF b) 1, basic fibroblast growth factor (FGF), and platelet-derived growth factor (PDGF) BB inhibit the synthesis of insulin-like growth factor (IGF) II, but their effects on IGF binding protein (IGFBP)-6 in osteoblast cultures are not kno
## Abstract The treatment of overuse tendon injuries with exogenous growth factors such as insulin‐like growth factor‐I (IGF‐I) may facilitate an improved return to sustained athletic function. The biological effects of IGF‐I are exerted under the control of a complex of IGF receptors, binding prot
## Abstract Recent epidemiological studies have shown that high serum levels of insulin‐like growth factor‐I (IGF‐I) are associated with an increased risk of lung, colon, breast and prostate cancer. Since very few studies have addressed the role of serum levels of IGF‐I in the development of pancre
Rhabdomyosarcoma is the most common soft-tissue sarcoma of childhood. Rhabdomyosarcoma cell lines overexpress insulin-like growth factor-II (IGF-II), an autocrine growth factor that is inhibited by insulin-like growth factor binding protein-6 (IGFBP-6). IGFBP-6 is associated with myoblast quiescence